$29.39 −$0.06 (-0.20%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $29.35 -0.14%
开盘$29.07
昨收$29.45
当日区间$28.54 – $29.43
成交量48.32M
市值$167.52B
市盈率（TTM）42.0
股息率5.85%
PFE 相关新闻
匹配 Pfizer 或代码 PFE 的头条新闻，按最新排序。
- Dow Jones Top Company Headlines at 9 PM ET: Amazon Pauses Operations With 21 Air After Miami Crash | Pfizer ...
- Pfizer (PFE.US) Sees Signs of Recovery! New Drug Revenue Surges 18%, but Patent Cliff Remains the Biggest Challenge 正面
- Pfizer, BioNTech, and Moderna sought to have Bayer's Monsanto mRNA patent lawsuit dismissed, but the judge rejected their motion. 负面
- BridgeBio (BBIO.US) cardiac therapy acoramidis outperforms Pfizer’s (PFE.US) competitor drug in real-world study
- Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $29
- Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $28
- Pfizer (PFE.US) to share overseas price-hike gains with U.S. government: "Most-Favored-Nation" contract exposed, while over twenty deals remain confidential 正面
- HSBC Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $30 正面
- Guggenheim Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $31 负面
- Argus Research Maintains Pfizer(PFE.US) With Buy Rating
- DZ BANK AG Maintains Pfizer(PFE.US) With Buy Rating
- Cantor Fitzgerald Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $27
- Scotiabank Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $30
- Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $29 负面
- BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $30
暂无评论——快来第一个聊聊 PFE。
登录后参与讨论。